Cabot Corp. (CBT) Tops Q2 EPS by 2c; misses on guidance

Cabot Corp. (NYSE: CBT) reported Q2 EPS of $1.33, $0.02 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.11 billion.

GUIDANCE:

Cabot Corp. sees FY2023 EPS of $6.10-$6.50, versus the consensus of $6.45.

For earnings history and earnings-related data on Cabot Corp. (CBT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c